|
ABOUT COMPANY
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in Chicago, Illinois.
|
EARNINGS
Gross Profit (TTM): 11207000
Market Capitalization: 365397000
Operating Margin (TTM): -2.392
PE Ratio: None
PEG Ratio: 0
Profit Margin: -2.655
Revenue Per Share (TTM): 0.57
Revenue (TTM): 35333000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.171
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -1.514
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -94216000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|